Resumo

ARCOS SANCHEZ, C.; SALINAS VELA, F.T.  e  OLMEDILLA GONZALEZ, M.N.. New perspectives in the treatment of Multiple Sclerosis. Sanid. Mil. [online]. 2011, vol.67, n.2, pp.108-114. ISSN 1887-8571.

A best knowledge of etiopathogeny and prognosis of Multiple Sclerosis is allowing the development of new and more effective therapies. Current therapies are divided into three groups: treatments for the acute relapses, disease-modifying therapy and symptomatic treatment. There are six approved drugs available in Spain, also there are two oral new drugs (Cladribina and Fingolimod) and others designed for improving the quality of life of these patients (Frampidina and Sativex) waiting to be approved and some others in different stages of clinical trials that will offer encouraging perspectives in a near future.

Palavras-chave : Multiple sclerosis; Treatment; Drug therapy.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )